Category: 6. Health

This retrospective cohort study provides important real-world insights into the safety of DTG-based antiretroviral regimens among Thai PLHIV. Over half of the cohort (53.86%) experienced at least one ADE within the first year of DTG therapy. This…

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) lowered the risk of chronic kidney disease (CKD) progression regardless of patients’ estimated glomerular filtration rate (eGFR) or albuminuria, according to authors of a study published in…

Exercise has traditionally been associated with better health outcomes. According to the World Health Organization, there are various physical and mental health benefits to engaging in regular physical…

In total, the study included 1051 patients. Data for the training cohort were obtained from the phase 3 JAVELIN Renal 101 trial (NCT02684006), and data for the validation cohorts were collected from the phase 2 SURF (NCT02689167) and NIVOREN…

As many as 34 people died and 175 others were infected with the Japanese encephalitis (JE) virus that has spread to 117 local units of 45 districts of Nepal since June.

The number of deaths, death rate, and infections are at their highest in…

In a study carried out in collaboration with the World Health Organization, two Aston University academics have found that while access to antiseizure medication in low- and middle-income countries is growing, it is not necessarily…

As flu season begins in the US, following the deadliest flu outbreak in children outside of a pandemic since record-keeping began in 2004, pediatricians are taking the lead on vaccine messaging.

The US Centers for Disease Control and Prevention…

Liang Cheng, Director of Anatomic Pathology and Director of Molecular Pathology at Lifespan Academic Medical Center and Vice Chair for Translational Research at the Warren Alpert Medical School of Brown University, shared a post…

The past decade in advanced breast cancer (ABC) care has gone under the microscope, with a new study revealing dramatic advances in survival outcomes, while cautioning that life-extending drugs reach just 51% of low-middle income countries…